These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 25624330
21. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis. Lemaire S, Kosowska-Shick K, Julian K, Tulkens PM, Van Bambeke F, Appelbaum PC. Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801 [Abstract] [Full Text] [Related]
23. Development of High-Level Daptomycin Resistance in Abiotrophia and Granulicatella Species Isolates from Patients with Infective Endocarditis. Cañas MA, Téllez A, García de la Mària C, Dahl A, García-González J, Hernández-Meneses M, Almela M, Ambrosioni J, Falces C, Quintana E, Vidal B, Perissinotti A, Tolosana JM, Sandoval E, Pericàs JM, Moreno A, Miró JM, Hospital Clínic Endocarditis Team Investigators. Antimicrob Agents Chemother; 2021 Sep 17; 65(10):e0252220. PubMed ID: 34252304 [Abstract] [Full Text] [Related]
24. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. Cafini F, Aguilar L, González N, Giménez MJ, Torrico M, Alou L, Sevillano D, Vallejo P, Prieto J. J Antimicrob Chemother; 2007 Jun 17; 59(6):1185-9. PubMed ID: 17412725 [Abstract] [Full Text] [Related]
25. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations. Leonard SN, Rybak MJ. J Antimicrob Chemother; 2009 Jan 17; 63(1):155-60. PubMed ID: 18984644 [Abstract] [Full Text] [Related]
27. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL. Torrico M, Giménez MJ, González N, Alou L, Sevillano D, Cafini F, Prieto J, Cleeland R, Aguilar L. Int J Antimicrob Agents; 2010 Feb 17; 35(2):131-7. PubMed ID: 20006469 [Abstract] [Full Text] [Related]
28. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus. Torrico M, Aguilar L, Sevillano D, Giménez MJ, Alou L, González N, Cafini F, Cleeland R, Prieto J. Int J Antimicrob Agents; 2011 Apr 17; 37(4):332-8. PubMed ID: 21388792 [Abstract] [Full Text] [Related]
29. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents. Smith A, Jackson MS, Kennedy H. Scand J Infect Dis; 2004 Apr 17; 36(4):259-63. PubMed ID: 15198181 [Abstract] [Full Text] [Related]
30. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species. Rodríguez-Avial I, Rodríguez-Avial C, Culebras E, Picazo JJ. Antimicrob Agents Chemother; 2005 Feb 17; 49(2):820-3. PubMed ID: 15673778 [Abstract] [Full Text] [Related]
31. Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases. Han XY, Kamana M, Rolston KV. J Clin Microbiol; 2006 Jan 17; 44(1):160-5. PubMed ID: 16390964 [Abstract] [Full Text] [Related]
32. [Identification and antibiotic susceptibility of viridans group streptococci isolates recovered from patients hospitalized at a teaching hospital in Buenos Aires City]. Heine AC, García S, Barberis C, Vay C, E Mollerach M, Bonofiglio L, Famiglietti Á. Rev Argent Microbiol; 2019 Jan 17; 51(1):26-31. PubMed ID: 29941157 [Abstract] [Full Text] [Related]
39. Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. Prabhu RM, Piper KE, Baddour LM, Steckelberg JM, Wilson WR, Patel R. Antimicrob Agents Chemother; 2004 Nov 17; 48(11):4463-5. PubMed ID: 15504884 [Abstract] [Full Text] [Related]
40. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii. Córdoba J, Coronado-Álvarez NM, Parra D, Parra-Ruiz J. Antimicrob Agents Chemother; 2015 Dec 17; 59(12):7316-9. PubMed ID: 26369956 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]